Holdings of SymBiosis Capital Partners, LLC
4 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 100 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 72.4 %
- FR 27.6 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 3 | 34.3M $ | 72.40 % |
| 2 | FR | 1 | 13.1M $ | 27.60 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Evommune Inc | 1,280,778 | 29.4M $ | |
| 2 | Inventiva SACA | 2,354,000 | 13.1M $ | |
| 3 | Rani Therapeutics Holdings Inc | 3,667,585 | 2.7M $ | |
| 4 | CLENE INC | 431,094 | 2.1M $ |